131 related articles for article (PubMed ID: 2876772)
1. Intrapleural and intravenous Corynebacterium parvum in patients with resected stage I and II non-small cell carcinoma of the lung. The Ludwig Lung Cancer Study Group.
Ludwig Lung Cancer Study Group
Cancer Immunol Immunother; 1986; 23(1):1-4. PubMed ID: 2876772
[TBL] [Abstract][Full Text] [Related]
2. Adverse effect of intrapleural Corynebacterium parvum as adjuvant therapy in resected stage I and II non-small cell carcinoma of the lung. Ludwig Lung Cancer Study Group.
J Thorac Cardiovasc Surg; 1985 Jun; 89(6):842-7. PubMed ID: 2860271
[TBL] [Abstract][Full Text] [Related]
3. Immunostimulation with intrapleural BCG as adjuvant therapy in resected non-small cell lung cancer. The Ludwig Lung Cancer Study Group (LLCSG).
Cancer; 1986 Dec; 58(11):2411-6. PubMed ID: 2876770
[TBL] [Abstract][Full Text] [Related]
4. Treatment of malignant pleural effusions with intrapleural Corynebacterium parvum or tetracycline.
Leahy BC; Honeybourne D; Brear SG; Carroll KB; Thatcher N; Stretton TB
Eur J Respir Dis; 1985 Jan; 66(1):50-4. PubMed ID: 3979476
[TBL] [Abstract][Full Text] [Related]
5. A phase-II trial of Corynebacterium parvum as adjuvant to surgery in the treatment of operable lung cancer.
Woodruff M; Walbaum P
Cancer Immunol Immunother; 1983; 16(2):114-6. PubMed ID: 6362846
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin, cisplatin, and Corynebacterium parvum in non-small cell bronchogenic carcinoma.
Drapkin R; Bjornsson S; Naeher C; Higby D; Caracandas J; Wallens WT; Kuberka N; Suh K; Siddiqi N; Henderson ES
Cancer Treat Rep; 1980; 64(12):1367-9. PubMed ID: 7193520
[TBL] [Abstract][Full Text] [Related]
7. [Postoperative prevention of recurrence with intrapleural Corynebacterium parvum in patients with stage I and II bronchial carcinomas. Ludwig lung cancer study I].
Schweiz Med Wochenschr; 1979 Jun; 109(22):860-1. PubMed ID: 462160
[TBL] [Abstract][Full Text] [Related]
8. Clinical trial of Corynebacterium parvum (intra-lymph-node and intravenous) and radiation therapy in the treatment of head and neck carcinoma.
Cheng VS; Suit HD; Wang CC; Raker J; Kaufman S; Rothman K; Walker A; Mcnulty P
Cancer; 1982 Jan; 49(2):239-44. PubMed ID: 7032681
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy plus methanol extracted residue of bacillus Calmette-Guérin or Corynebacterium parvum in stage III lung cancer.
Bjornsson S; Takita H; Kuberka N; Preisler H; Catane H; Higby D; Henderson E
Cancer Treat Rep; 1978 Apr; 62(4):505-10. PubMed ID: 350388
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the toxicity of two formulations of Corynebacterium parvum in a double-blind crossover trial in patients with bronchogenic carcinoma.
Mitcheson HD; Priestman TJ
Clin Oncol; 1981 Sep; 7(3):179-82. PubMed ID: 7044635
[No Abstract] [Full Text] [Related]
11. Phase III study on the treatment of women with cervical cancer, stage IIB, IIIB, and IVA (confined to the pelvis and/or periaortic nodes), with radiotherapy alone versus radiotherapy plus immunotherapy with intravenous Corynebacterium parvum: a Gynecologic Oncology Group Study.
DiSaia PJ; Bundy BN; Curry SL; Schlaerth J; Thigpen JT
Gynecol Oncol; 1987 Mar; 26(3):386-97. PubMed ID: 3549476
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of neoplastic pleural effusion by intrapleural administration of Corynebacterium parvum vaccine].
Krasucka-Kluźniak A; Krakówka P
Pneumonol Pol; 1985 May; 53(5):240-7. PubMed ID: 4047949
[No Abstract] [Full Text] [Related]
13. Moderate to high dose cyclophosphamide and intercalated Corynebacterium parvum in patients with metastatic lung cancer.
Thatcher N; Honeybourne D; Wagstaff J; Carroll KB; Barber PV; Morrison JB; Crowther D
Br J Dis Chest; 1984 Jan; 78(1):89-97. PubMed ID: 6318791
[TBL] [Abstract][Full Text] [Related]
14. Lung cancer patients treated with Corynebacterium parvum. Phase I toxicity study.
Yadeau R; Bates HA; Fortuny I
Minn Med; 1979 Sep; 62(9):673-5. PubMed ID: 503003
[No Abstract] [Full Text] [Related]
15. Surgery plus Corynebacterium parvum immunotherapy for Lewis lung carcinoma in mice.
Karrer K; Rella W; Goldin A
Eur J Cancer (1965); 1979 Jun; 15(6):867-73. PubMed ID: 499275
[No Abstract] [Full Text] [Related]
16. Chemotherapy versus chemoimmunotherapy with levamisole or Corynebacterium parvum in advanced lung cancer.
Chahinian AP; Goldberg J; Holland JF; Reisman A; Jaffrey IS; Mandel EM
Cancer Treat Rep; 1982 Jun; 66(6):1291-7. PubMed ID: 6282455
[TBL] [Abstract][Full Text] [Related]
17. Combination chemoimmunotherapy for extensive non-oat cell lung cancer.
Issell BF; Valdivieso M; Hersh EM; Richman S; Gutterman JU; Bodey GP
Cancer Treat Rep; 1978 Jul; 62(7):1059-63. PubMed ID: 356968
[TBL] [Abstract][Full Text] [Related]
18. Intrapleural immunotherapy with Corynebacterium parvum in recurrent malignant pleural effusions.
Millar JW; Hunter AM; Horne NW
Thorax; 1980 Nov; 35(11):856-8. PubMed ID: 7221983
[TBL] [Abstract][Full Text] [Related]
19. Canine oral melanoma: comparison of surgery versus surgery plus Corynebacterium parvum.
MacEwen EG; Patnaik AK; Harvey HJ; Hayes AA; Matus R
Cancer Invest; 1986; 4(5):397-402. PubMed ID: 3801954
[TBL] [Abstract][Full Text] [Related]
20. [Hematological observations in patients following immunostimulation through intrapleural application of Corynebacterium parvum].
Karrer K; Denck H; Pridun N
Acta Med Austriaca; 1979; 6(5):209-12. PubMed ID: 233458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]